5-Amino-1MQ

Certificate of Analysis & Complete Test Results

✓ Verified & Certified
Test Date
Jan 30, 2026
Batch Number
110168
Purity Level
99.31%

Certificate of Analysis

High-Performance Liquid Chromatography

Client: Peptides Canada
Sample Name: Semaglutide
Batch #: 110168
Report Date: 07/14/2025
Test: Purity
Receipt Date: 07/12/2025
Analysis Date: 07/14/2025
Matrix: Powder
Number of samples: 1
Purity: 99.31%

Research-grade specification: ≥95.0% — this batch exceeds specification.

Date File 110168_MS2_posneg_Semaglutide_Lot110168_purity.d Sample Name Semaglutide_Lot110168_purity
Sample Type Sample Position P6-30
Instrument Name LCMS-7800 Series Username -
Acq Method Semaglutide_purity_2mg.m Acquired 07/14/2025 10:45:22 AM
IRM Calibration Status Calibrated Time (UTC-07:00)
Comment Sample test for purity of Semaglutide batch 110168 DA Method SignalToNoiseCheckout.m
Sample Group Test Batch 3 Info. -
Stream Name LC1 Acquisition 07/14/2025 10:45:22 AM
Acquisition SW Version 6400 Series Triple Quadrupole B.09.00 (89037.0) Time (Local) (UTC-07:00)

Peak List

Time Area % Area
6.92 min 4987.3 99.31 %
8.45 min 34.1 0.69 %

* determined as Semaglutide based on retention time

Note: Percent area between two compounds is not quantitative due to variable extinction coefficients.

Test Screen

UV Chromatogram:

Identity: Semaglutide

(Other names: NNC 0113-0217, Sermaglutide)

CAS: 910462-68-2

Data

Mass Spectrum

MSMS ID — head to tail database matching

Mass Spectrum Peptide Envelope encompasses the 3-6 positive change states conferring Peptide Mass

Semaglutide

Expected Mass: 4113.58

Observed Mass: 4113.60

Reviewed and approved by:

Herman Lelie

Pepslab.ca LLC. All test results are the responsibility of the client. This report relates only to the samples tested. The analyses were performed except as indicated. Samples are within quality control criteria and area specifications unless noted.